Esmo Breast Cancer 2021: analysis of two important studies presented during the congress Oncologia Brasil agora é Med IQ 3:26 3 years ago 267 Далее Скачать
ESMO 2021 breast cancer highlights: TULIP and KEYNOTE-355 VJOncology 2:34 3 years ago 95 Далее Скачать
Expert report on tackling resistance to CDK4/6 inhibitors in ER+/HER2-metastatic breast cancer European Society for Medical Oncology (ESMO) 4:50 2 years ago 1 390 Далее Скачать
#ESMO21 Expert Video Report on HER2-positive early breast cancer European Society for Medical Oncology (ESMO) 8:31 3 years ago 1 363 Далее Скачать
Expert Commentary: Melanoma, Breast and Gynaecological Cancers at ESMO Congress 2021 European Society for Medical Oncology (ESMO) 10:15 3 years ago 452 Далее Скачать
#ESMO21 Expert Video Report on HER2-positive metastatic breast cancer European Society for Medical Oncology (ESMO) 7:30 3 years ago 1 415 Далее Скачать
ESMO Daily Reporter Talk: The role of CDK4/6 inhibitors in the early stage of #breastcancer. European Society for Medical Oncology (ESMO) 21:47 4 years ago 1 234 Далее Скачать
Expert Commentary: Developmental therapeutics at ESMO Congress 2021 European Society for Medical Oncology (ESMO) 10:19 3 years ago 558 Далее Скачать
#ESMO21 Expert Video Report on targeting in HER2-positive metastatic breast and lung cancers European Society for Medical Oncology (ESMO) 5:45 3 years ago 786 Далее Скачать
ASCO 2021 - Highlights on shifting PARPi to Early Breast Cancer: The OlympiA study European Society for Medical Oncology (ESMO) 6:16 3 years ago 1 903 Далее Скачать
